Home › Endocrine Diseases › Washington
Endocrine Diseases clinical trials in Washington
4 studies for Endocrine Diseases are looking for participants at sites in Washington.
Cities in Washington
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Spokane Valley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07081997Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Seattle
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Nov 5, 2026 · NCT07221851METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RecruitingPhase 2
Ages 18 to 69 · All sexes · Updated Sep 15, 2026 · NCT07699380Rare and Atypical Diabetes Network
- University of Washington, Seattle
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.